Lilly Settles Zyprexa Claims With Idaho

The Idaho State Attorney General Lawrence Wasden yesterday announced that the state and Eli Lilly have reached a settlement of claims the state had made of illegal off-label marketing of Zyprexa by the company. The settlement is for $13 million, which brings Lilly's total payouts for Zyprexa claims to about $2.8 billion. Lilly has now settled claims with almost three dozen states.

According to a statement from Wasden's office, Lilly admits no wrongdoing in the settlement.